Skip to content
  • BiotechReality JobFinder
  • Market Analysis
  • Publish on BiotechReality
  • linkedin
  • facebook
  • instagram
  • twitter
BiotechReality Home
BiotechReality – Information Intelligence System for Biopharma
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
Popular
#FDA #Eli Lilly and Company #Johnson&Johnson #Clinical Data #FDA Approval #Cancer #Novo Nordisk #Quarterly Results

Category: Toxicology

Deep Learning News Research Toxicology

Deep learning develops proteins that protect against the venom of deadly snakes

  • By Editor's Desk
  • 16 January 2025
RVV V Russelss Viper

Researchers from the Technical University of Denmark and the UW Medicine Institute for Protein Design are spearheading a computational biology initiative to find more effective antivenom treatments.

Tagged Deep Learning, Snake Venom
Biotechnology News Toxicology

CRISPR technology paves the way for a new antidote for Cobra bites

  • By Editor's Desk
  • 19 July 2024
Cobra Snake Image

Every year, hundreds of individuals are killed by cobra venom, and an estimated 100,000 more suffer severe injuries from necrosis, which is the loss of bodily tissue and cells and can result in amputation.

Tagged Cobra Venom, CRISPR
Research Toxicology

Research: Deadly snakebite toxins can be neutralized with a synthetic antibody

  • By Editor's Desk
  • 25 February 2024
Cobra Snake Image

This is the first time that this particular strategy is being applied to develop antibodies for snakebite treatment.

Tagged Antibodies, Snake Venom
Toxicology

Russell’s Viper – Hemotoxic Venom | Details – Types, Effects, and Pharmacology

  • By Achuth B S
  • 10 October 2023
Russell's Viper - Hemotoxic Venom | Details – Types, Effects, and Pharmacology

Russel’s Viper is highly venomous and possesses hemotoxic venom (RVV – Russel’s Viper Venom) which is highly lethal. A small jab with the fangs can transfer a large amount of venom, which can cause coagulopathies, internal bleeding, tissue damage (necrosis), and acute kidney injury.

Tagged Russel's Viper, Venom
Toxicology

Cobra’s Neurotoxic Venom | Details – Types, Effects, and Pharmacology

  • By Achuth B S
  • 15 September 2023
Cobra Snake Image

Elapidae is a family of poisonous snakes that includes the cobras. They are recognized for their unusual looks, deadly venom, and the capacity to lift the front portion of their bodies when attacked, generating a distinctive hood shape.

Tagged Cobra Snake, Cobra Venom
Advertisement

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Autoimmune Diseases
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biologics
  • Biosimilars
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • CDMO
  • Cell Biology
  • Clinical Data
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • CRDMO
  • CRO
  • Cybersecurity
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Legal and Patent Affairs
  • Life Sciences
  • Machine Learning
  • Manufacturing
  • Medical Devices
  • Mental Health
  • Merger & Acquisitions
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Rare Diseases
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs

Discover More

Novo Ozempic 2 mg MACE Analysis Shows 6% Lower Cardiovascular Risk Versus Switching to Mounjaro at EASD 2026
Research Healthcare & Pharmaceuticals News

Novo Ozempic 2 mg MACE Analysis Shows 6% Lower Cardiovascular Risk Versus Switching to Mounjaro at EASD 2026

29 September 202629 September 2026
Clinical Trials & Data Desk
AbbVie Valkai AI Partnership Deploys Purpose-Built AI Across Targeted Clinical Development Areas
Artificial Intelligence Business Healthcare & Pharmaceuticals News

AbbVie Valkai AI Partnership Deploys Purpose-Built AI Across Targeted Clinical Development Areas

29 September 202629 September 2026
BiotechReality Business Intelligence Desk
Novo HRS-1596 License: Novo Secures Hengrui Pharma’s Oral Once-Weekly GLP-1/GIP Agonist in Deal Worth Up to $2.6 Billion
Business Healthcare & Pharmaceuticals News

Novo HRS-1596 License: Novo Secures Hengrui Pharma’s Oral Once-Weekly GLP-1/GIP Agonist in Deal Worth Up to $2.6 Billion

29 September 202629 September 2026
BiotechReality Business Intelligence Desk
Merck SPR2015 KRAS G12D Inhibitor Deal Strengthens Oncology Pipeline Through $2.13 Billion Agreement
Business Healthcare & Pharmaceuticals News Research

Merck SPR2015 KRAS G12D Inhibitor Deal Strengthens Oncology Pipeline Through $2.13 Billion Agreement

28 September 202628 September 2026
BiotechReality Business Intelligence Desk
AbbVie JUVMO (Tavapadon) Wins FDA Approval as First Selective D1/D5 Receptor Agonist for Parkinson’s Disease
Regulatory Approval Clinical Data Healthcare & Pharmaceuticals News

AbbVie JUVMO (Tavapadon) Wins FDA Approval as First Selective D1/D5 Receptor Agonist for Parkinson’s Disease

28 September 202628 September 2026
Regulatory Intelligence Desk
Merck Ifinatamab Deruxtecan BLA Withdrawn in Previously Treated ES-SCLC
Clinical Data Healthcare & Pharmaceuticals News Regulatory

Merck Ifinatamab Deruxtecan BLA Withdrawn in Previously Treated ES-SCLC

27 September 202627 September 2026
Clinical Trials & Data Desk
Advertisement
BiotechReality JobFinder

  • Component Engineer – Cytiva, Bangalore
    29 September 2026
  • Manufacturing Manager – Novartis, Japan
    28 September 2026
  • Principal Application Specialist FMT APAC – Sartorius, Singapore
    27 September 2026
  • Product Manager – Sanofi, Taipei
    26 September 2026
  • Associate QA Analyst – IQVIA
    14 September 2026

BiotechReality Shots Weekly Newsletter

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2026
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
  • linkedin
  • facebook
  • instagram
  • twitter